Lord’s Mark Industries Limited has partnered with the Centre for Materials for Electronic Technology (CMET) to develop an AI-driven, radiation-free breast screening wearable device. This breakthrough technology aims to provide an alternative to traditional mammography, making breast cancer detection more accessible and comfortable for women.
The global breast cancer market was valued at $4,822.14 million in 2023 and is expected to grow at a 9.22% CAGR, reaching $12,880.85 million by 2035. This wearable device uses AI-powered temperature mapping to detect early-stage abnormalities through non-invasive thermal sensors.
Key Features of the Device:
- Radiation-Free & Non-Invasive: Eliminates radiation exposure and discomfort associated with conventional mammography.
- AI-Driven Thermal Detection: Uses advanced thermal sensors and AI algorithms to identify breast abnormalities.
- Wearable & User-Friendly: Designed for use in hospitals, clinics, and homes, providing dignity and comfort.
The device is a joint venture between Lord’s Mark and CMET, funded by Thuliba Buli Limited. It is expected to be commercially available globally, with Lord’s Mark Industries planning to launch it internationally, making breast cancer screening more affordable and accessible for women worldwide.
